Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Breast cancer
(-)
= Neoadjuvant chemotherapy
(-)
= Charehbili, A.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(4)
+
-
Availability
Metadata Only
(4)
+
-
Creation Date
2016
(2)
+
-
2019
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Topic
Breast cancer
(4)
+
-
Zoledronic acid
(3)
+
-
IGF-1R
(2)
+
-
Insulin
(2)
+
-
Pathological complete response
(2)
+
-
Author
Kroep, J.R.
(4)
+
-
Smit, V.T.H.B.M.
(4)
+
-
Hoeven, J.J.M. van der
(3)
+
-
Nortier, J.W.R.
(3)
+
-
Putter, H.
(3)
+
-
Dekker-Ensink, N.G.
(2)
+
-
Dutch Breast Canc Res Grp
(2)
+
-
Groot, S. de
(2)
+
-
Heijns, J.B.
(2)
+
-
Kessels, L.W.
(2)
+
-
Kranenbarg, E.M.K.
(2)
+
-
Laarhoven, H.W.M. van
(2)
+
-
Liefers, G.J.
(2)
+
-
Pijl, H.
(2)
+
-
Velde, C.J.H. van de
(2)
+
-
Ven, S. van de
(2)
+
-
Show more
Language
en
(4)
+
-
Search results
(1 - 4 of 4)
show grid
show list
save search
Groot, S. de; Pijl, H.; Charehbili, A.; Ven, S. van de; Smit, V.T.H.B.M.; Meershoek-Klein Kranenbarg, E.; ... ; Dutch Breast Canc Res Grp
2019
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)
Article / Letter to editor
metadata only
Groot, A.F. de; Blok, E.J.; Charehbili, A.; Engels, C.C.; Smit, V.T.H.B.M.; Dekker-Ensink, N.G.; ... ; Kroep, J.R.
2019
Strong CD8+lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
Article / Letter to editor
metadata only
Charehbili, A.; Hamdy, N.A.T.; Smit, V.T.H.B.M.; Kessels, L.; Bochove, A. van; Laarhoven, H.W. van; ... ; Dutch Breast Canc Res Grp BOOG
2016
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Article / Letter to editor
metadata only
Groot, S. de; Charehbili, A.; Laarhoven, H.W.M. van; Mooyaart, A.L.; Dekker-Ensink, N.G.; Ven, S. van de; ... ; Dutch Breast Canc Res Grp
2016
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Article / Letter to editor
metadata only